Synklino

synklino.com

Synklino is a Danish biotech company focused on developing transformative therapies to eliminate the risk of chronic viral diseases, particularly cytomegalovirus (CMV) infections in transplant recipients. Their key product, SYN002, aims to improve the quality of life for these patients by either treating the donor organ before transplantation or the recipient after. With a strong emphasis on scientific excellence and a diverse team, Synklino is positioned to become a market leader in the chronic infectious diseases space, backed by significant funding and a commitment to addressing unmet medical needs.